{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "IgG",
      "IgM",
      "SARS-CoV-2",
      "antibody",
      "coronavirus",
      "diagnosis"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33289157",
  "DateCompleted": {
    "Year": "2021",
    "Month": "04",
    "Day": "05"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "07",
    "Day": "16"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "01",
        "Day": "13"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1002/cbin.11516"
    ],
    "Journal": {
      "ISSN": "1095-8355",
      "JournalIssue": {
        "Volume": "45",
        "Issue": "4",
        "PubDate": {
          "Year": "2021",
          "Month": "Apr"
        }
      },
      "Title": "Cell biology international",
      "ISOAbbreviation": "Cell Biol Int"
    },
    "ArticleTitle": "Serological tests for COVID-19: Potential opportunities.",
    "Pagination": {
      "StartPage": "740",
      "EndPage": "748",
      "MedlinePgn": "740-748"
    },
    "Abstract": {
      "AbstractText": [
        "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel betacoronavirus, caused a pandemic leading to a standstill of nearly all global activities. There are some controversies on the production of specific immunoglobulin M (IgM) and IgG antibodies after the infection with SARS-CoV-2. This paper seeks to elaborate on the potential application of IgM and IgG antibodies and the viral antigens for the diagnosis and the course of the disease as well as the recurrence of positive nucleic acid tests after discharge."
      ],
      "CopyrightInformation": "\u00a9 2020 International Federation for Cell Biology."
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-7645-9999"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "School of Medicine, Tehran University of Medical Sciences, Tehran, Iran."
          },
          {
            "Identifier": [],
            "Affiliation": "Biomedical Engineering Unit, University of Ghana Medical Center (UGMC), Accra, Ghana."
          },
          {
            "Identifier": [],
            "Affiliation": "Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Accra, Ghana."
          }
        ],
        "LastName": "Tantuoyir",
        "ForeName": "Marcarious M",
        "Initials": "MM"
      },
      {
        "Identifier": [
          "0000-0002-3836-1827"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "School of Medicine, Tehran University of Medical Sciences, Tehran, Iran."
          },
          {
            "Identifier": [],
            "Affiliation": "Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran."
          },
          {
            "Identifier": [],
            "Affiliation": "Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran."
          }
        ],
        "LastName": "Rezaei",
        "ForeName": "Nima",
        "Initials": "N"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Cell Biol Int",
    "NlmUniqueID": "9307129",
    "ISSNLinking": "1065-6995"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies, Viral"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antigens, Viral"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Immunoglobulin G"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Immunoglobulin M"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Cell Biol Int. 2021 Nov;45(11):2198",
      "PMID": "34351662"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Antibodies, Viral"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "Antigens, Viral"
    },
    {
      "QualifierName": [
        "immunology",
        "pathology",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Immunoglobulin G"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Immunoglobulin M"
    },
    {
      "QualifierName": [
        "immunology",
        "isolation & purification",
        "metabolism"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Serologic Tests"
    }
  ],
  "CoiStatement": "The authors declare that there are no conflict\u00a0of interests."
}